Xiangjun Qian

6PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 17, 2026
An Integrative Multi-Omic Biomarker Panel Distinguishes Hepatocellular Carcinoma From Chronic Liver Disease in HBV-Predominant Populations.

|Apr 10, 2026
Hepatocyte-derived LRG1 primes the liver for metastasis and impairs immunotherapy.

Guojie Long, Bing Cheng, Yue Jiang

|Jan 14, 2026
PSMD1 inhibition suppresses tumor progression and enhances antitumor immunity by modulating the RTKN/β-catenin/PD-L1 axis in hepatocellular carcinoma.

Xiangjun Qian, Kai Zhang, Chao Ma

|Aug 26, 2022
The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients.

Xiangjun Qian, Yanna Liu, Fengping Wu

|Aug 28, 2020
Reappraisal of the diagnostic value of alpha-fetoprotein for surveillance of HBV-related hepatocellular carcinoma in the era of antiviral therapy.

Xiangjun Qian, Shuhong Liu, Huiling Long

|Oct 23, 2019
Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries.

Xiangjun Qian, Sujun Zheng, Leijie Wang

Pageof 1

Frequent Collaborators

2 joint publications

Fengmin Lu

2 joint publications

Hao Zhuang

1 joint publications

Zhongping Duan

1 joint publications

Xiangmei Chen